Korro Bio Inc
For the period ended Mar 31, 2024. Filed May 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 14, 2024
KRRO$14.75+0.1%Stored close · as of Nov 6, 2026
Contents
Condensed Consolidated Balance Sheets
(amounts in thousands, except share and par value amounts)
| March 31,2024 | December 31,2023 | |
|---|---|---|
| Assets: | ||
| Current assets: | ||
| Cash and cash equivalents | $138,804 | $166,150 |
| Restricted cash | 3,546 | 3,563 |
| Prepaid expenses and other current assets | 3,305 | 3,015 |
| Total current assets | 145,655 | 172,728 |
| Property and equipment, net | 20,509 | 15,665 |
| Operating lease right-of-use assets | 25,947 | 27,150 |
| Restricted cash, net of current portion | 3,406 | 3,406 |
| Other non-current assets | 2,468 | 2,714 |
| Total assets | $197,985 | $221,663 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $4,657 | $7,280 |
| Accrued expenses and other current liabilities | 5,161 | 10,212 |
| Operating lease liabilities, current portion | 1,235 | 1,991 |
| Total current liabilities | 11,053 | 19,483 |
| Operating lease liabilities, net of current portion | 34,681 | 31,216 |
| Other non-current liabilities | 893 | 1,053 |
| Total liabilities | 46,627 | 51,752 |
| Commitments and contingencies (Note 11) | ||
| Stockholders’ equity | ||
| Preferred stock, $0.001 par value; 10,000,000 shares authorized at March 31, 2024 and December 31, 2023; no shares issued and outstanding at March 31, 2024 and December 31, 2023 | — | — |
| Common stock, $0.001 par value; 200,000,000 shares authorized at March 31, 2024 and December 31, 2023; 8,022,463 shares and 8,016,516 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 8 | 8 |
| Additional paid-in capital | 353,912 | 352,908 |
| Accumulated deficit | (202,562) | (183,005) |
| Total stockholders’ equity | 151,358 | 169,911 |
| Total liabilities and stockholders' equity | $197,985 | $221,663 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.